OneSource Specialty Pharma Limited (ONESOURCE): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for OneSource Specialty Pharma Limited, explained in plain English.

• ▪OneSource Specialty Pharma Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪ONESOURCE closed at ₹1,553.00 on 30 October 2026.
• ▪Over the past year the shares are down 16.0%, trading between ₹1,057.00 and ₹1,925.00.
• ▪Reported fundamentals show return on equity of -0.03%, a net margin of -0.1%, debt to equity of 29.64.
• ▪Our transparent MaxGrade checklist scores it D (48/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 44.77% with a maximum drawdown of -40.68% and a beta of -0.12 against NIFTY 50.
• ▪Recent coverage: OneSource Specialty Pharma shares jump 14% after Q2 results; recover 50% from recent lows

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Figures from the current session. Market open.